APA (7th ed.) Citation

W, L., M, P., & J, T. (2026). Aloe-emodin ameliorates non-alcoholic fatty liver disease by regulating the ZNRF3/Wnt/β-catenin axis and suppressing hepatic lipogenesis. Biochemical and biophysical research communications, 827, 153979. https://doi.org/10.1016/j.bbrc.2026.153979

Chicago Style (17th ed.) Citation

W, Li, Pan M, and Tang J. "Aloe-emodin Ameliorates Non-alcoholic Fatty Liver Disease by Regulating the ZNRF3/Wnt/β-catenin Axis and Suppressing Hepatic Lipogenesis." Biochemical and Biophysical Research Communications 827 (2026): 153979. https://doi.org/10.1016/j.bbrc.2026.153979.

MLA (9th ed.) Citation

W, Li, et al. "Aloe-emodin Ameliorates Non-alcoholic Fatty Liver Disease by Regulating the ZNRF3/Wnt/β-catenin Axis and Suppressing Hepatic Lipogenesis." Biochemical and Biophysical Research Communications, vol. 827, 2026, p. 153979, https://doi.org/10.1016/j.bbrc.2026.153979.